oral administration of ciprofibrate , a potent hypolipidemic compound , to rats for 2 or more weeks at doses of 20 mg/kg/day or more resulted in hypertrophy and increased eosinophilia of the oxyntic cells in the gastric mucosa .
C0030559
oxyntic cells
C0017136
gastric mucosa